MIPI (Mantle Cell Lymphoma Prognostic Index)
MIPI (Mantle Cell Lymphoma Prognostic Index) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the MIPI (Mantle Cell Lymphoma Prognostic Index) → Runs in your browser. No signup, no tracking.
What this is
MIPI (Mantle Cell Lymphoma Prognostic Index) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. MIPI (Mantle Cell Lymphoma Prognostic Index) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Hoster E, Dreyling M, Klapper W, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558-565. Read the source ↗
Worked example: MIPI 6.07 — intermediate risk.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.